title: Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?
authors.affiliation: Multi-Organ Transplant Program, University of Toronto, Toronto, Ontario, Canada. david.grant@uhn.on.ca
authors.forename: David
authors.initials: D
authors.lastname: Grant
authors.forename: Robert A
authors.initials: RA
authors.lastname: Fisher
authors.forename: Michael
authors.initials: M
authors.lastname: Abecassis
authors.forename: Geoffrey
authors.initials: G
authors.lastname: McCaughan
authors.forename: Linda
authors.initials: L
authors.lastname: Wright
authors.forename: Sheung-Tat
authors.initials: ST
authors.lastname: Fan
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D018572:Disease-Free Survival; D046148:Donor Selection; D019317:Evidence-Based Medicine; D006305:Health Status Indicators; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects / Q000401:mortality; D019520:Living Donors / Q000600:supply & distribution*; D009364:Neoplasm Recurrence, Local; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome